In Reply
- PMID: 33481520
- DOI: 10.1097/AOG.0000000000004273
In Reply
Conflict of interest statement
Financial Disclosure The authors did not report any potential conflicts of interest.
Comment on
-
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).Obstet Gynecol. 2020 Oct;136(4):823-826. doi: 10.1097/AOG.0000000000004103. Obstet Gynecol. 2020. PMID: 32769659
-
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).Obstet Gynecol. 2021 Feb 1;137(2):378-379. doi: 10.1097/AOG.0000000000004272. Obstet Gynecol. 2021. PMID: 33481518 No abstract available.
References
-
- Saad AF, Chappell L, Saade GR, Pacheco LD. Corticosteroids in the management of pregnant patients with coronavirus disease (COVID-19). Obstet Gynecol 2020;136:823–6. doi: 10.1097/AOG.0000000000004103 - DOI
-
- WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 2020;324:1330–41. doi: 10.1001/jama.2020.17023 - DOI
-
- World Health Organization. Corticosteroids for COVID-19. Living guidance. Accessed November 17, 2020. https://www.who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-20...
-
- National Institutes of Health. COVID-19 treatment guidelines: corticosteroids. Accessed November 17, 2020. https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immu...
-
- Raikkonen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA 2020;323:1924–33. doi: 10.1001/jama.2020.3937 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical